| 1 |
Olivier Morand |
Hoffmann-La Roche |
20 |
| 2 |
Francis Hubler |
Actelion Pharmaceuticals |
19 |
| 3 |
Sophie Marquais-Bienewald |
Basf Se |
13 |
| #4 |
Christian Loesche |
Galderma Research & Development |
12 |
| #5 |
Andre Schmitter |
Ciba-Geigy |
11 |
| #6 |
Sebastien Jacquier |
Novartis Ag |
8 |
| #7 |
Richard Heng |
Novartis Ag |
6 |
| #7 |
Marc Faller |
Basf Se |
6 |
| #9 |
Philippe Nussbaum |
Ciba-Geigy |
4 |
| #9 |
Antoine Hirth |
Institut Franco-Allemand De Recherches De Saint-Louis |
4 |
| #9 |
Patrice Guitard |
Novartis Ag |
4 |
| #12 |
Werner Kanert |
Ciba Specialty Chemicals |
3 |
| #12 |
Christiane Guitard |
Novartis Ag |
3 |
| #12 |
Jean-Marie Sire |
Ciba-Geigy |
3 |
| #15 |
Claude Jeannerat |
Ciba-Geigy |
2 |
| #15 |
Grazia Piizzi |
Novartis Ag |
2 |
| #15 |
Guillermo Bellido |
Novozymes A/S |
2 |
| #15 |
Andr e Schmitter |
Ciba-Geigy |
2 |
| #19 |
Pier Luca D'Alessandro |
Novartis Ag |
1 |
| #19 |
Henri Angly |
Contraves |
1 |
| #19 |
Cliff Beard |
Huntsman International |
1 |
| #19 |
Guy Taccard |
Unknown |
1 |
| #19 |
Yves Victor René DUDAL |
— |
1 |
| #19 |
Patrick Bohrer |
Dsm Ip Assets B.V. |
1 |
| #19 |
Lionel ROUX |
Siegfried Ag |
1 |
| #19 |
Jean-Marc Dutter |
Merck |
1 |
| #19 |
Denis Stöcklin |
— |
1 |